Danaher plans $7b purchase of Beckman Coulter Danaher Corp. said it would acquire biomedical testing equipment company Beckman Coulter Inc. for about $6.8 billion, including debt.
The D.C. company said it planned to buy all the outstanding shares of Beckman Coulter for a cash price of $83.50 a share. After the assumption of debt and net of any cash acquired, the value of the acquisition would be approximately $6.8 billion.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.